Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT06267859

Development of Methods for Effective Treatment and Improvement of Common Somatic Diseases in Children

Conditions: Respiratory Diseases, Congenital Heart Defects

Sex: All
Ages: 3 Days – 15 Years
Healthy volunteers: No
Phase: EARLY_PHASE1
Enrollment: 600
Sponsor: Tashkent State Medical University (Tashkent Pediatric Medical Institute), Uzbekistan

Location: Turdieva Shokhida Tolkunovna Tashkent Yunus-obad District

Summary

The goal of the clinical study is to clarify the course of common congenital, infectious, and non-infectious diseases in children living in Uzbekistan, and to develop methods for their treatment and rehabilitation. The main questions it aims to answer: * Analysis of common congenital diseases among children; * Analysis of the most frequently diagnosed bronchopulmonary (acute bronchitis with and without obstruction, congenital pneumonia, acute and chronic pneumonia) and cardiovascular diseases in children; * Based on the results of the primary research, common diseases among children will be identified; * Analysis of existing treatment methods and their effectiveness; * Development of modern methods of treatment and rehabilitation of children.

Eligibility Criteria

Inclusion Criteria: * children from birth to 15 years; * children permanently residing in the territory where the clinical examination is carried out; \- children with acute bronchitis; * children included in the group of "frequently ill children"; * patients without severe chronic diseases. Exclusion Criteria: * Teenagers over 15 years old; * Patients with severe neurological and mental diseases; * Patients with endocrinological diseases; * Patients with long-term chronic somatic diseases; * Children without genetic pathologies.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT06267859). StuddyBuddy aggregates publicly available trial information.